...
首页> 外文期刊>Journal of Medicinal Plants Research >Hypoglycaemic effects of Salvia officinalis extracts on alloxan-induced diabetic Swiss albino mice
【24h】

Hypoglycaemic effects of Salvia officinalis extracts on alloxan-induced diabetic Swiss albino mice

机译:丹参癌蛋白酶蛋白糖尿病瑞士白血菌小鼠丹参蛋白酶提取物的低血糖作用

获取原文
           

摘要

Diabetes mellitus is the fourth killer disease globally. The available management strategies are quite expensive and sometimes unsafe. This necessitates the need for bio-active drugs from medicinal plants. Although Salvia officinalis (sage) is used in herbal medicine, the scientific validation for anti-diabetic effects of various extracts has been elusive. The present study aimed to determine and compare the anti-hyperglycaemic efficacy of methanolic, hexane, ethyl acetate, and aqueous leaf extracts of Salvia officinalis in alloxan-induced diabetic mice. Phytochemical screening of the extracts revealed presence of flavanone, sterols, saponins, tannins, alkaloids, and triterpenes. The extracts were subjected to preliminary in vivo bio-assays at dosage levels of 400 mg/kg for 7 days through oral administration. The aqueous extract demonstrated significant hypoglycaemic effect, p?0.05 hence subjected to further hypoglycaemic studies for 15 days. There was a significant decrease in blood sugar levels of groups treated with aqueous extract at 400 mg/kg and 600 mg/kg doses from 452.00 ± 11.13 mg/dL and 431.00 ± 10.65 mg/dL to 256.33 ± 5.12 mg/dL and 256.67 ± 8.74 mg/dL. Weight gain improved significantly from 28.05 ± 0.39 g and 27.38 ± 0.52 g to 29.32 ± 0.42 g and 28.55 ± 0.38 g respectively compared to controls, p?0.05. Histopathological studies revealed no significant changes in liver and kidney tissues. Besides, no significant cytotoxic effect was reported. Results from this study indicate that aqueous extract of Salvia officinalis is a potential anti-hyperglycaemic and can be used in modulating blood glucose levels.
机译:糖尿病是全球第四次杀手疾病。可用的管理策略非常昂贵,有时是不安全的。这需要需要来自药用植物的生物活性药物。虽然Salvia Officinalis(Sage)用于草药,但各种提取物的抗糖尿病效应的科学验证已经难以捉摸。本研究旨在确定和比较甲醇,己烷,乙酸乙酯和丹昔尼蛋白酶诱导的糖尿病小鼠的抗高血糖疗效。提取物的植物化学筛选揭示了黄烷酮,甾醇,皂苷,单宁,生物碱和三岭的存在。通过口服给药在400mg / kg的剂量水平下的体内生物测定中进行初步萃取物。水性提取物展示了显着的低血糖效应,P?0.05因此在15天内进行进一步的低血糖研究。用400mg / kg和600mg / kg的含水提取物处理的血糖水平的显着降低,40.00±11.13mg / dl和431.00±10.65mg / d1至256.33±5.12 mg / dl和256.67± 8.74 mg / dl。重量增益在28.05±0.39g和27.38±0.52g至29.32±0.42g和27.32±0.42g和28.55±0.38g的情况下,与对照相比,P 2 0.05分别从27.32±0.42g。组织病理学研究表明肝肾组织没有显着变化。此外,没有报道任何显着的细胞毒性效果。本研究的结果表明,丹参的水性提取物是潜在的抗高血糖,可用于调节血糖水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号